focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 99.50
Bid: 98.00
Ask: 101.00
Change: -1.50 (-1.49%)
Spread: 3.00 (3.061%)
Open: 101.00
High: 101.00
Low: 99.50
Prev. Close: 101.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supply Agreement

13 Jul 2022 07:00

RNS Number : 2508S
Concurrent Technologies PLC
13 July 2022
 

 

This announcement contains inside information

 

13 July 2022

Concurrent Technologies Plc

("Concurrent Technologies" or the 'Company')

Supply Agreement with Global Medical Technology Company

 

Concurrent Technologies, a world leading specialist in the design and manufacture of high-end embedded computer boards for critical applications, has entered into a supply agreement with a Fortune 500 global medical technology company, and has received an initial USD$2.2 million order for first year product shipments. Initial shipments have already commenced for qualification purposes with volume shipments scheduled to start at the end of 2022. The customer is then expected to place similar size orders on an annual basis for several years to come.

The customer's needs were multi-faceted and challenging. Concurrent Technologies developed a product that maintained backwards compatibility with the external interfaces of the prior product; demonstrated the ability to manage and overcome issues that would prevent multi-year production without changes; and met all the customer's quality and supply chain requirements. Concurrent Technologies also ported the customer's application software to work seamlessly on the new hardware, accelerating the introduction of the customer's next generation machine.

Dr. Miles Adcock, CEO of Concurrent Technologies, commented: "We pride ourselves on delivering extremely reliable products to a very high-quality standard which suits customers from many vertical market segments including medical. The required product was developed at pace in line with the expectation we have set for increasing the cadence of new product introductions. With the customer intending to place similar size orders on an annual basis for several years to come, this is expected to provide a steady revenue stream that is wholly accretive to our current business."

 

Enquiries:

Concurrent Technologies Plc

Miles Adcock, CEO +44 (0)1206 752626

 

SEC Newgate (Financial PR)

Bob Huxford +44 (0)20 3757 6880

Isabelle Smurfit +44 (0)20 3757 6880

Group email concurrent@secnewgate.co.uk

 

Cenkos Securities Plc (NOMAD)

Neil McDonald +44 (0)131 220 9771

Peter Lynch +44 (0)131 220 9772

 

About Concurrent Technologies Plc

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 9th generation embedded Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRSFSEEEEESEDW
Date   Source Headline
5th May 201510:40 amRNSPosting of Annual Report & Accounts
9th Apr 20154:49 pmRNSDirector/PDMR Shareholding
31st Mar 201512:55 pmRNSHolding(s) in Company
31st Mar 201510:18 amRNSDirector/PDMR Shareholding
30th Mar 20153:14 pmRNSDirector/PDMR Shareholding
30th Mar 201511:19 amRNSGrant of Share Options
30th Mar 201510:19 amRNSHolding(s) in Company
26th Mar 20157:00 amRNSFinal Results
24th Mar 20152:07 pmRNSHolding(s) in Company
19th Mar 201512:07 pmRNSNotice of Results
25th Feb 20152:42 pmRNSSecond Interim Dividend
24th Feb 20157:00 amRNSProduct Update
23rd Feb 20157:00 amRNSProduct Launch
20th Jan 20157:00 amRNSProduct Launch
23rd Dec 201412:00 pmRNSPre Close Trading Update
15th Dec 201410:20 amRNSProduct Update
3rd Sep 20143:07 pmRNSLaunch of Three XMC Storage Adapters
28th Aug 20142:47 pmRNSHolding(s) in Company
26th Aug 20147:00 amRNSHalf Yearly Report
19th Aug 20143:14 pmRNSNotice of Interim Results
18th Jul 20142:21 pmRNSExport Regulations Update
1st Jul 20144:15 pmRNSExport Regulations Update
23rd Jun 20147:00 amRNSProduct Launch
27th May 20142:03 pmRNSAGM Statement
13th May 20142:08 pmRNSProduct Launch
10th Apr 20141:19 pmRNSHolding(s) in Company
8th Apr 201412:15 pmRNSDirector/PDMR Shareholding
1st Apr 20149:26 amRNSDistribution of Annual Report
25th Mar 20147:00 amRNSFinal Results
19th Mar 201412:36 pmRNSNotice of Results
17th Feb 20144:18 pmRNSHolding(s) in Company
27th Dec 20137:00 amRNSTrading Update
13th Dec 20134:31 pmRNSProduct Launch
6th Dec 20131:35 pmRNSHolding(s) in Company
28th Nov 201311:31 amRNSHolding(s) in Company
1st Nov 20133:45 pmRNSTotal Voting Rights
24th Oct 20134:13 pmRNSProduct Launch
23rd Oct 20132:56 pmRNSTransaction in Own Shares
8th Oct 20132:35 pmRNSProduct Launch
4th Oct 20135:01 pmRNSTransaction in Own Shares
1st Oct 20133:13 pmRNSTotal Voting Rights
25th Sep 20132:38 pmRNSTransaction in Own Shares
4th Sep 20132:42 pmRNSTransaction in Own Shares
22nd Aug 20137:00 amRNSInterim Results
16th Aug 20133:58 pmRNSNotice of Results
12th Aug 201312:40 pmRNSTrading Update
21st Jun 201312:20 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSProduct Launch
28th May 20132:00 pmRNSAGM Statement
24th May 20133:10 pmRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.